As described by others, LCs are very efficient in cross-presenting peptides to CD8+ T cells, which acquire potent cytotoxicity and are able to efficiently kill target cells, including tumor cell lines that express peptide-HLA complex, only at low amounts [172] in an IL-15-dependent manner. Here, CD8A is linked to neoplasm.